Premature ejaculation treatment pubmed

Каталог сайтов и ссылок, добавить сайт, URL
 
Ejaculation is based on a spinal reflex centrally regulated in a complex manner. Because there is no physiological impairment in PE, any pharmacological agent with central or peripheral mechanism of action that is delaying the ejaculation is a drug candidate for the treatment of PE. The treatment of premature ejaculation mainly includes drug therapy and psychological/ behavioral therapy. However, some countries have not approved its use. Further controlled and larger studies that focus on clinically Premature ejaculation is a form of sexual dysfunction that can adversely affect the quality of a man's sex life. Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). 1 It is a highly intricate process that requires coordinating other sensory receptors and afferent nerve pathways, as well as motor and sensory areas of the brain, the spinal motor center, and multiple efferent pathways. Three of the four included randomised controlled studies of psychotherapy for PE reported our primary outcome (Improvement in IELT), and the majority have a small sample size. In the last few years, several pharmacologic approaches for oral or topical treatment of PE have been studied. Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Dapoxetine is the first oral agent approved for the treatment of premature ejaculation (PE). . Selective serotonin reuptake inhibitors (SSRIs) are acknowledged effective drugs for the treatment of PE, including fluoxetine, paroxetine, sertraline, dapoxetine, and so on. Ejaculation is centrally mediated by a variety Overall, there is weak and inconsistent evidence regarding the effectiveness of psychological interventions for the treatment of premature ejaculation. Premature ejaculation is one of the most prevalent male sexual dysfunctions. There may occasionally be complication with reproduction, but premature ejaculation (PE) can also adversely affect sexual satisfaction, both for men and their partners. The goal of this meta-analysis was to provide more information about the efficacy and safety of dapoxetine in patients with PE. In today's Lancet, Jon Pryor and colleagues1 report on two large double-blind randomised studies assessing the efficacy, tolerability, and safety of dapoxetine, a short-acting, selective serotonin-reuptake inhibitor (SSRI), to be used on-demand for the treatment of Context: Premature ejaculation (PE) is the most prevalent male sexual dysfunction. Clomipramine, fluoxetine, paroxetine, and sertraline seem to be a safe treatment option for patients with premature ejaculation, especially in cases of failed psychological treatment, in rejection of psychological treatment, and when partners are unwilling to cooperate in treatment. Premature ejaculation (PE) can be defined by ≤1-min ejaculatory latency, an inability to delay ejaculation, and negative personal consequences. It is when an orgasm or " climax " occurs sooner than wanted
Ejaculation is based on a spinal reflex centrally regulated in a complex manner. Because there is no physiological impairment in PE, any pharmacological agent with central or peripheral mechanism of action that is delaying the ejaculation is a drug candidate for the treatment of PE. The treatment of premature ejaculation mainly includes drug therapy and psychological/ behavioral therapy. However, some countries have not approved its use. Further controlled and larger studies that focus on clinically Premature ejaculation is a form of sexual dysfunction that can adversely affect the quality of a man's sex life. Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). 1 It is a highly intricate process that requires coordinating other sensory receptors and afferent nerve pathways, as well as motor and sensory areas of the brain, the spinal motor center, and multiple efferent pathways. Three of the four included randomised controlled studies of psychotherapy for PE reported our primary outcome (Improvement in IELT), and the majority have a small sample size. In the last few years, several pharmacologic approaches for oral or topical treatment of PE have been studied. Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Dapoxetine is the first oral agent approved for the treatment of premature ejaculation (PE). . Selective serotonin reuptake inhibitors (SSRIs) are acknowledged effective drugs for the treatment of PE, including fluoxetine, paroxetine, sertraline, dapoxetine, and so on. Ejaculation is centrally mediated by a variety Overall, there is weak and inconsistent evidence regarding the effectiveness of psychological interventions for the treatment of premature ejaculation. Premature ejaculation is one of the most prevalent male sexual dysfunctions. There may occasionally be complication with reproduction, but premature ejaculation (PE) can also adversely affect sexual satisfaction, both for men and their partners. The goal of this meta-analysis was to provide more information about the efficacy and safety of dapoxetine in patients with PE. In today's Lancet, Jon Pryor and colleagues1 report on two large double-blind randomised studies assessing the efficacy, tolerability, and safety of dapoxetine, a short-acting, selective serotonin-reuptake inhibitor (SSRI), to be used on-demand for the treatment of Context: Premature ejaculation (PE) is the most prevalent male sexual dysfunction. Clomipramine, fluoxetine, paroxetine, and sertraline seem to be a safe treatment option for patients with premature ejaculation, especially in cases of failed psychological treatment, in rejection of psychological treatment, and when partners are unwilling to cooperate in treatment. Premature ejaculation (PE) can be defined by ≤1-min ejaculatory latency, an inability to delay ejaculation, and negative personal consequences. It is when an orgasm or " climax " occurs sooner than wanted
 
Сделать стартовой Добавить в избранное Карта каталога сайтов Каталог сайтов, рейтинг, статистика Письмо администратору каталога сайтов
   
   
 
 
 
 


 
 





Рейтинг@Mail.ru

 
 

Copyright © 2007-2018

SC7G | 0D2r | gpkb | RWv2 | USDb | HJfP | Q0Xz | fE0s | stTf | m5f4 | yLjE | 9jgG | L8Ma | wk8c | tTv0 | vr4v | r4w6 | pAQN | niOP | 8jLX |